v3.25.2
Collaborative and Other Relationships - Stoke Therapeutics, Inc. (Details) - USD ($)
$ in Millions
1 Months Ended
Feb. 28, 2025
Jun. 30, 2025
Zorevunersen    
Collaborative arrangements and non-collaborative arrangement transactions    
Percentage of future development costs 30.00%  
Stoke Therapeutics Inc    
Collaborative arrangements and non-collaborative arrangement transactions    
Upfront and milestone paymentsmade to collaborative partner $ 165.0  
Stoke Therapeutics Inc | Zorevunersen    
Collaborative arrangements and non-collaborative arrangement transactions    
Percentage of future development costs 70.00%  
Stoke Therapeutics Inc | Milestone Payment, Developmental    
Collaborative arrangements and non-collaborative arrangement transactions    
Estimated additional payments upon achievement of development and commercial milestones   $ 50.0
Stoke Therapeutics Inc | Milestone Payment, Commercial    
Collaborative arrangements and non-collaborative arrangement transactions    
Estimated additional payments upon achievement of development and commercial milestones   $ 335.0